• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 09, 2023 at 11:22: AM
via AstraZeneca has inked a definitive agreement to acquire cardiorenal disease player CinCor Pharma in a deal that could potentially reach $1.8 billion in total value, the companies announced Monday.

article source
 

<



Similar threads

cafead
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
Replies
0
Views
136
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
Replies
0
Views
138
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis&#039; AveXis buys AstraZeneca site in Colorado as it anticipates gene therapy launch
Replies
0
Views
859
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca steps out from Daiichi&#039;s shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote